Keyword: Genentech


Genentech Builds Biologics Facility in California

17.02.2023 -

Genentech, the US biotech arm of Swiss pharma giant Roche, is building a new small-batch biologics manufacturing facility at its Oceanside campus in California, USA...


Bill Anderson to Be Bayer CEO from June 1

10.02.2023 -

Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player...


Genentech Takes Jecure Therapeutics

02.12.2018 - Genentech, part of Swiss drugs giant Roche, has agreed to buy Jecure Therapeutics, a US biotech focused on discovering novel treatments for non-alcoholic steatohepatitis (NASH) and...


FDA Approves Genentech Flu Drug

29.10.2018 - The US Food and Drug Administration (FDA) has approved a new drug produced by Genentech to treat acute uncomplicated influenza (flu) in patients 12 years of age and older who have...


Affimed and Genentech in Immunotherapy Pact

04.09.2018 - German biopharma Affimed has agreed a strategic collaboration with Genentech, part of Swiss drug giant Roche, to develop immunotherapies for multiple cancers. Affimed will apply...


Roche Sues Pfizer to Block Herceptin Copy

24.11.2017 - In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...


Genentech Returns Cancer Drug Rights to NewLink

16.06.2017 - US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...


US Firms Urge Trump to Uphold Paris Accord

12.01.2017 - More than 350 companies headquartered or with operations in the US, including such diverse enterprises as Monsanto, Genentech, Unilever, L’Oreal USA and the Merck Family Fund...